Decitabine and Zantac drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Decitabine (decitabine) and Zantac (ranitidine hydrochloride). Common drug interactions include white blood cell count decreased among females and hyperbilirubinaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Decitabine and Zantac. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Decitabine?

Decitabine has active ingredients of decitabine. eHealthMe is studying from 4,605 Decitabine users. Check the latest studies of Decitabine.

What is Zantac?

Zantac has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 434,161 Zantac users. Check the latest studies of Zantac.

On Jul, 11, 2026

15 people who take Decitabine and Zantac together, and have interactions are studied.

Decitabine and Zantac drug interactions.

What are the common drug interactions of Decitabine and Zantac, by gender? *:

female:

White blood cell count decreased
Anal abscess
Apnoea (suspension of external breathing)
Blood creatinine increased
Death
Dry skin
Enterobacter pneumonia (lung inflammation caused by bacteria of the family enterobacteriaceae)
Febrile neutropenia (fever with reduced white blood cells)
Hypernatraemia (an abnormally high plasma concentration of sodium ions)
Ileus (a painful obstruction of the ileum or other part of the intestine)

male:

Hyperbilirubinaemia (excess of bilirubin in the blood)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Globulins decreased
Infection
Neutropenia (an abnormally low number of neutrophils)
Oropharyngeal pain
Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Heart rate increased

What are the common drug interactions of Decitabine and Zantac, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Aspartate aminotransferase increased
Blood urea increased
Blood urea nitrogen/creatinine ratio increased
Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Hospitalisation
Viraemia (presence of a virus in the blood stream)

20-29:

n/a

30-39:

Death

40-49:

Febrile neutropenia (fever with reduced white blood cells)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Lobar pneumonia (a form of pneumonia that affects a large and continuous area of the lobe of a lung)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

50-59:

n/a

60+:

White blood cell count decreased
Anaemia (lack of blood)
Infection
Oropharyngeal pain
Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)
Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
Heart rate increased
Hypotension (abnormally low blood pressure)
Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
Thrombocytopenia (decrease of platelets in blood)

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 10 people, 66.67%
White Blood Cell Count Decreased: 3 people, 20.00%
Thrombocytopenia (decrease of platelets in blood): 3 people, 20.00%
Serum Ferritin Increased: 3 people, 20.00%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 3 people, 20.00%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 20.00%
The Flu (the flu is caused by an influenza virus): 1 person, 6.67%
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 1 person, 6.67%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 6.67%
Mucosal Inflammation (infection of mucous membrane): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Decitabine and Zantac?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously